This HTML5 document contains 45 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.1212/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q70514725
rdf:type
wikibase:Item
schema:description
artículu científicu espublizáu en setiembre de 1993 scientific article published on 01 September 1993 article scientifique publié en 1993 im September 1993 veröffentlichter wissenschaftlicher Artikel wetenschappelijk artikel наукова стаття, опублікована у вересні 1993
p:P577
wds:Q70514725-635BDD21-74FD-4646-A2F7-BA36F899A409
wdt:P577
1993-09-01T00:00:00Z
p:P407
wds:Q70514725-E281B6AC-75AD-4FFF-AAB0-B5667EB6EB65
wdt:P407
wd:Q1860
p:P2093
wds:Q70514725-E84A296B-DC11-4273-AF09-CC4D84CD61CA wds:Q70514725-D00DC1BF-3094-44B0-BE27-CDE165D33DEF wds:Q70514725-B5A18FD4-501F-4CB9-844F-093CA7791326 wds:Q70514725-85EC2A59-1094-4F30-B979-9537833FD7B7 wds:Q70514725-559E6C27-CF34-4DB5-85B9-6E17BEBDFFEB
wdt:P2093
N Bathien P Rondot J de Recondo M Zuber M Sebald
rdfs:label
Botulinum antibodies in dystonic patients treated with type A botulinum toxin: frequency and significance Botulinum antibodies in dystonic patients treated with type A botulinum toxin: frequency and significance
skos:prefLabel
Botulinum antibodies in dystonic patients treated with type A botulinum toxin: frequency and significance Botulinum antibodies in dystonic patients treated with type A botulinum toxin: frequency and significance
schema:name
Botulinum antibodies in dystonic patients treated with type A botulinum toxin: frequency and significance Botulinum antibodies in dystonic patients treated with type A botulinum toxin: frequency and significance
p:P1476
wds:Q70514725-8679C73F-F2CF-459C-8633-DCBF989D59C5
wdt:P1476
Botulinum antibodies in dystonic patients treated with type A botulinum toxin: frequency and significance
p:P304
wds:Q70514725-5EF7BC9F-4FAE-470A-AAA1-5B57A34D07C4
wdt:P304
1715-1718
p:P31
wds:Q70514725-C45A260D-E332-4BC4-BE84-59972485EB73
wdt:P31
wd:Q13442814
p:P698
wds:Q70514725-AD1E68C4-0A75-4B90-A4F1-97A6418D701E
wdtn:P698
n11:8414019
wdt:P698
8414019
p:P1433
wds:Q70514725-9509A00E-7FCC-4A02-97E8-041322C71CEA
wdt:P1433
wd:Q1161692
p:P433
wds:Q70514725-C7714832-A51A-493C-954E-957A96195F61
p:P478
wds:Q70514725-A1C8842B-1584-4657-B381-54613A860E23
wdt:P433
9
wdt:P478
43
p:P356
wds:Q70514725-CA7A0DD4-B619-47D0-92A5-7FA984C9C66B
wdtn:P356
n10:WNL.43.9.1715
wdt:P356
10.1212/WNL.43.9.1715